Department of Respiratory Medicine, St John of God, Perth, Western Australia, Australia.
Department of Respiratory Medicine, Middlemore Hospital, Auckland, New Zealand.
Intern Med J. 2021 Mar;51(3):436-441. doi: 10.1111/imj.15230.
Lung cancer remains the commonest cause of cancer death in Australia and New Zealand. Targeted screening of individuals at highest risk of lung cancer aims to detect early stage disease, which may be amenable to potentially curative treatment. While current policy recommendations in Australia and New Zealand have acknowledged the efficacy of lung cancer screening in clinical trials, there has been no implementation of national programmes. With the recent release of findings from large international trials, the evidence and experience in lung cancer screening has broadened. This article discusses the latest evidence and implications for Australia and New Zealand.
肺癌仍然是澳大利亚和新西兰癌症死亡的最常见原因。对肺癌高危人群进行有针对性的筛查旨在发现早期疾病，这些疾病可能适合进行潜在的治愈性治疗。虽然澳大利亚和新西兰的现行政策建议已经承认了临床试验中肺癌筛查的疗效，但尚未实施国家方案。随着最近大型国际试验结果的公布，肺癌筛查的证据和经验也有所扩大。本文讨论了最新的证据及其对澳大利亚和新西兰的影响。
